SCHEMBL6709949

SCHEMBL6709949

O=C(Nc1ccc(Cl)cc1-c1noc(=O)[nH]1)c1noc2ccc(S(=O)(=O)N3CCOCC3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
MAPK1 P28482 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALB P02768 1/20 0.46
TP53 P04637 1/20 0.45
NPC1 O15118 1/20 0.44
ATM Q13315 3/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CNR1 P21554 1/20 0.43
GPR35 Q9HC97 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
USP2 O75604 1/20 0.43
CREBBP Q92793 1/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710405 0.91 ALB (0.46) MAPTMEN1KMT2AALBTP53
SCHEMBL6711876 0.89 ALB (0.48) MAPTALBATMLMNASMN1; SMN2
SCHEMBL6713434 0.87 MAPT (0.47) MAPTMAPK1NPSR1MEN1KMT2A
SCHEMBL6710165 0.83 ALDH1A1 (0.40) MAPTMEN1KMT2ANPC1LMNA
SCHEMBL6711925 0.81 ALDH1A1 (0.47) MAPTMAPK1NPSR1MEN1KMT2A
SCHEMBL6708781 0.81 HIF1A (0.45) MEN1KMT2ATP53
SCHEMBL6708495 0.80 HIF1A (0.45)
SCHEMBL6708659 0.80 GRIK1 (0.51) MAPTMEN1KMT2ATP53LMNA
SCHEMBL6709902 0.80 HIF1A (0.44) MEN1KMT2ARXFP1
SCHEMBL2885426 0.80 KMT2A (0.59) MAPTMAPK1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MAPT 4754/4885MAPK1 2728/4885NPSR1 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.